- 专利标题： Methods and compositions for treating cystic fibrosis
-
申请号： US15308626申请日： 2015-05-08
-
公开(公告)号： US11052132B2公开(公告)日： 2021-07-06
- 发明人: Susan Arnold , David James Ballance
- 申请人： PHASEBIO PHARMACEUTICALS, INC.
- 申请人地址： US PA Malvern
- 专利权人： PHASEBIO PHARMACEUTICALS, INC.
- 当前专利权人： PHASEBIO PHARMACEUTICALS, INC.
- 当前专利权人地址： US PA Malvern
- 代理机构： Cooley LLP
- 国际申请： PCT/US2015/029926 WO 20150508
- 国际公布： WO2015/172046 WO 20151112
- 主分类号： A61K38/22
- IPC分类号： A61K38/22 ; A61K31/404 ; A61K31/443 ; A61K31/47 ; A61K38/39 ; A61K45/06
摘要：
The present disclosure provides a method of treating diseases or disorders associated with CFTR protein dysfunction, including Cystic Fibrosis, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more elastin-like peptides and can be administered at a low-dose.
公开/授权文献
- US20170182130A1 METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS 公开/授权日：2017-06-29
信息查询
IPC分类:
